30 results on '"S. Shamimi-Noori"'
Search Results
2. Abstract No. 103 Changes in the Match: Results of an IR Applicant and Program Director Survey Regarding Virtual Interviews and Step 1 Pass/Fail
- Author
-
M. Matsumoto, D. DePietro, S. Shamimi-Noori, J. Hoffmann, T. Gade, S. Reddy, and G. Nadolski
- Subjects
Radiology, Nuclear Medicine and imaging ,Cardiology and Cardiovascular Medicine - Published
- 2023
3. Abstract No. 346 Iatrogenic renal artery injury: arteriogram findings and outcomes after embolization
- Author
-
M. Matsumoto, M. Dagli, S. Reddy, G. Nadolski, S. Shamimi-Noori, S. Trerotola, and W. Stavropoulos
- Subjects
Radiology, Nuclear Medicine and imaging ,Cardiology and Cardiovascular Medicine - Published
- 2022
4. Abstract No. 284 Demographic trends in female interventional radiology trainees with the advent of the integrated interventional radiology residency: a 12-month update
- Author
-
R. Parikh, S. Shamimi-Noori, S. Reddy, T. Gade, G. Nadolski, and S. Hunt
- Subjects
Radiology, Nuclear Medicine and imaging ,Cardiology and Cardiovascular Medicine - Published
- 2022
5. Abstract No. 173 Driver mutations predict response to transarterial chemoembolization in unresectable hepatocellular carcinoma
- Author
-
M. Kurian, K. Weinfurtner, D. Ackerman, A. Woodard, W. Li, E. Furth, E. Siegelman, D. Jhala, M. Soulen, M. Dagli, S. Shamimi-Noori, J. Mondschein, D. Sudheendra, W. Stavropoulos, S. Reddy, G. Nadolski, D. Kaplan, S. Hunt, and T. Gade
- Subjects
Radiology, Nuclear Medicine and imaging ,Cardiology and Cardiovascular Medicine - Published
- 2022
6. Abstract No. 208 Outcomes of PTFE-covered stent grafts for central venous disease in hemodialysis patients
- Author
-
K. Kanter, A. Vance, S. Trerotola, R. Cohen, S. Shamimi-Noori, M. Mantell, G. Nadolski, and T. Clark
- Subjects
Radiology, Nuclear Medicine and imaging ,Cardiology and Cardiovascular Medicine - Published
- 2022
7. 3:36 PM Abstract No. 296 To evaluate the effects of increased medical student exposure to interventional radiology on interest in and basic knowledge of interventional radiology
- Author
-
S. Shamimi-Noori and J. Do
- Subjects
medicine.medical_specialty ,Basic knowledge ,medicine.diagnostic_test ,business.industry ,Medicine ,Radiology, Nuclear Medicine and imaging ,Medical physics ,Interventional radiology ,Cardiology and Cardiovascular Medicine ,business - Published
- 2018
8. Accessory draining vein embolization in the salvage of nonfunctioning arteriovenous fistulae
- Author
-
S. Shamimi-Noori, Scott A. Resnick, and Kent T. Sato
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Fistula ,Retrospective cohort study ,medicine.disease ,Surgery ,medicine.anatomical_structure ,Angioplasty ,Medicine ,Radiology, Nuclear Medicine and imaging ,Embolization ,Radiology ,Hemodialysis ,Cardiology and Cardiovascular Medicine ,business ,Ligation ,Vein ,Dialysis - Abstract
Purpose The potential benefit of accessory vein embolization in the clinical setting of immature arteriovenous fistulae is unknown. We tested the hypothesis that embolization of accessory draining veins in immature arteriovenous fistulae facilitates maturation. Materials and Methods In this single-center retrospective study, we reviewed all diagnostic fistulagrams performed for the indication of non-maturing arteriovenous fistulae from 2005-2012. Patients, whose fistulas could not be used for dialysis and had not received prior therapy, were selected. Of these, we identified the subset of patients who had prominent venous collaterals that were felt to be clinically significant who then underwent coil embolization of these vessels with or without angioplasty. Medical records were examined to determine if the fistulae had matured to allow for hemodialysis through the fistula. These results were then compared with historical data utilizing surgical ligation with or without angioplasty. Results 31 patients were identified who had either coil embolization alone (n=17) or embolization in conjunction with angioplasty (n=14). Of the patients who had coil embolization, 84% (n=26) matured and were able to be used for dialysis. This compares favorably to historical surgical data which reported a salvage rate of 82.5%. 16% of fistulae (n=5) were treated, but did not mature and were abandoned. There were no complications related to embolization reported. Conclusion Surgical ligation of accessory veins has been validated as a therapy for salvage of immature dialysis fistulae. We have shown that endovascular coil embolization of accessory draining veins results in salvage rates similar to conventional surgical ligation.
- Published
- 2013
9. Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter Trial.
- Author
-
Savsani E, Shaw CM, Forsberg F, Wessner CE, Lyshchik A, O'Kane P, Liu JB, Balasubramanya R, Roth CG, Naringrekar H, Keith SW, Tan A, Anton K, Bradigan K, Civan J, Schultz S, Shamimi-Noori S, Hunt S, Soulen MC, Mattrey RF, Kono Y, and Eisenbrey JR
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Contrast Media, Prospective Studies, Treatment Outcome, Young Adult, Adult, Carcinoma, Hepatocellular diagnostic imaging, Carcinoma, Hepatocellular therapy, Chemoembolization, Therapeutic methods, Liver Neoplasms diagnostic imaging, Liver Neoplasms therapy, Liver Neoplasms pathology
- Abstract
Background Contrast-enhanced (CE) US has been studied for use in the detection of residual viable hepatocellular carcinoma (HCC) after locoregional therapy, but multicenter data are lacking. Purpose To compare two-dimensional (2D) and three-dimensional (3D) CE US diagnostic performance with that of CE MRI or CT, the current clinical standard, in the detection of residual viable HCC after transarterial chemoembolization (TACE) in a prospective multicenter trial. Materials and Methods Participants aged at least 21 years with US-visible HCC scheduled for TACE were consecutively enrolled at one of three participating academic medical centers from May 2016 to March 2022. Each underwent baseline 2D and 3D CE US before TACE, 2D and 3D CE US 1-2 weeks and/or 4-6 weeks after TACE, and CE MRI or CT 4-6 weeks after TACE. CE US and CE MRI or CT were evaluated by three fellowship-trained radiologists for the presence or absence of viable tumors and were compared with reference standards of pathology (18%), angiography on re-treatment after identification of residual disease at 1-2-month follow-up imaging (31%), 4-8-month CE MRI or CT (42%), or short-term (approximately 1-2 months) CE MRI or CT if clinically decompensated and estimated viability was greater than 50% at imaging (9%). Diagnostic performance criteria, including sensitivity and specificity, were obtained for each modality and time point with generalized estimating equation analysis. Results A total of 132 participants were included (mean age, 64 years ± 7 [SD], 87 male). Sensitivity of 2D CE US 4-6 weeks after TACE was 91% (95% CI: 84, 95), which was higher than that of CE MRI or CT (68%; 95% CI: 58, 76; P < .001). Sensitivity of 3D CE US 4-6 weeks after TACE was 89% (95% CI: 81, 94), which was higher than that of CE MRI or CT ( P < .001), with no evidence of a difference from 2D CE US ( P = .22). CE MRI or CT had 85% (95% CI: 76, 91) specificity, higher than that of 4-6-week 2D and 3D CE US (70% [95% CI: 56, 80] and 67% [95% CI: 53, 78], respectively; P = .046 and P = .023, respectively). No evidence of differences in any diagnostic criteria were observed between 1-2-week and 4-6-week 2D CE US ( P > .21). Conclusion The 2D and 3D CE US examinations 4-6 weeks after TACE revealed higher sensitivity in the detection of residual HCC than CE MRI or CT, albeit with lower specificity. Importantly, CE US performance was independent of follow-up time. Clinical trial registration no. NCT02764801 © RSNA, 2023 Supplemental material is available for this article.
- Published
- 2023
- Full Text
- View/download PDF
10. A 5-Year Update on the IR Residency Match: 2022 National Survey Results of Program Directors and Matched Applicants Compared with 2017.
- Author
-
Matsumoto MM, Shamimi-Noori S, Gade TP, Hoffmann JC, Nadolski GJ, and DePietro DM
- Subjects
- Humans, Male, Female, Surveys and Questionnaires, Phenotype, Research Personnel, Schools, Medical, Internship and Residency
- Abstract
Purpose: To characterize the experiences of matched applicants (MAs) and program directors (PDs) in the 2022 interventional radiology (IR) residency Match and compare with 2017 data., Methods: Surveys were distributed to IR PDs and MAs from the 2022 Match. Findings were compared with those of 2017 using the 2-sample t test and Fisher exact test., Results: In total, 68 MAs (40%) and 47 PDs (52%) responded. Collected demographic traits were similar, including ongoing male predominance (77% of MAs, 83% of PDs). Moreover, 86% of MAs and 87% of PDs were "satisfied" with Match outcomes. Compared with those in 2017, MAs applied to more IR programs (P < .001). MAs reported more research (P = .003) and abstracts/publications (P < .001) and ranked these as more important than PDs did (P < .001 for both). Approximately 82% of PDs gave special attention to candidates who completed a visiting rotation at their institution; 60% of MAs and 95% of PDs believed virtual interviews resulted in overinterviewing (P < .001); both agreed they provided convenience and accessibility. Furthermore, 63% of MAs believed a Step 1 pass/fail system will be less equitable for applicants. Additional data on demographics, medical school experiences, applications, interviews, intern year, and rank process were reported., Conclusions: Satisfaction with Match results remained high from 2017 to 2022, although efforts are needed to improve applicants' ability to navigate the application process, address overapplying, and evaluate concerns regarding the Step 1 pass/fail system. These survey findings will help inform applicants and PDs for future match cycles., (Copyright © 2023 SIR. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
11. Iatrogenic Renal Artery Injury in 90 Cases: Arteriographic Findings and Outcomes after Embolization for Bleeding.
- Author
-
Matsumoto MM, Reddy SN, Nadolski GJ, Shamimi-Noori S, Trerotola SO, and Stavropoulos SW
- Subjects
- Humans, Renal Artery injuries, Hemorrhage therapy, Angiography, Nephrectomy methods, Iatrogenic Disease, Retrospective Studies, Embolization, Therapeutic methods, Abdominal Injuries therapy, Acute Kidney Injury
- Abstract
Purpose: To evaluate differences in arteriographic findings and outcomes after embolization among patients with a suspected iatrogenic renal arterial injury (IRAI)., Materials and Methods: Patients at the authors' institution who underwent renal arteriography for suspected IRAIs after partial nephrectomy, biopsy, or percutaneous access over a 20-year period were included. Records, imaging, and outcomes were reviewed. Data analysis was performed using the Fisher exact or Kruskal-Wallis test., Results: Ninety arteriograms were performed on 83 patients after partial nephrectomy (n = 32), biopsy (n = 27), or percutaneous access (n = 24), including for nephrostomy/ureterostomy and stone removal. The median number of days between the index procedure and arteriogram was highest (15 days) after partial nephrectomy and lowest (5 days) after biopsy (P = .0001). Embolization was performed during 76% of arteriograms. If prearteriographic imaging showed positive results for IRAIs, embolization was performed in 67% versus 33% if imaging showed negative results (P = .005). The transfusion rate was higher after biopsy than after partial nephrectomy or percutaneous access (P = .002). Acute kidney injury after arteriogram occurred in 7% of patients; however, all returned to baseline by 1 week., Conclusions: Despite the different mechanism of IRAIs in partial nephrectomy, biopsy, and percutaneous access, arteriographic findings and outcomes were overall similar among groups. Prearteriographic imaging can help identify IRAIs but cannot supersede the clinical judgment regarding indication for embolization. IRAIs can present acutely or after a long interim, although patients who underwent biopsy presented earlier and more frequently required a blood transfusion. IRAIs can be treated with embolization without permanent deleterious effects on renal function., (Copyright © 2022 SIR. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
12. Variability in biopsy quality informs translational research applications in hepatocellular carcinoma.
- Author
-
Weinfurtner K, Cho J, Ackerman D, Chen JX, Woodard A, Li W, Ostrowski D, Soulen MC, Dagli M, Shamimi-Noori S, Mondschein J, Sudheendra D, Stavropoulos SW, Reddy S, Redmond J, Khaddash T, Jhala D, Siegelman ES, Furth EE, Hunt SJ, Nadolski GJ, Kaplan DE, and Gade TPF
- Subjects
- Aged, Biopsy, Carcinoma, Hepatocellular surgery, Female, Humans, Liver Neoplasms surgery, Male, Prospective Studies, Carcinoma, Hepatocellular pathology, Liver Neoplasms pathology, Specimen Handling standards, Translational Research, Biomedical standards
- Abstract
In the era of precision medicine, biopsies are playing an increasingly central role in cancer research and treatment paradigms; however, patient outcomes and analyses of biopsy quality, as well as impact on downstream clinical and research applications, remain underreported. Herein, we report biopsy safety and quality outcomes for percutaneous core biopsies of hepatocellular carcinoma (HCC) performed as part of a prospective clinical trial. Patients with a clinical diagnosis of HCC were enrolled in a prospective cohort study for the genetic, proteomic, and metabolomic profiling of HCC at two academic medical centers from April 2016 to July 2020. Under image guidance, 18G core biopsies were obtained using coaxial technique at the time of locoregional therapy. The primary outcome was biopsy quality, defined as tumor fraction in the core biopsy. 56 HCC lesions from 50 patients underwent 60 biopsy events with a median of 8 core biopsies per procedure (interquartile range, IQR, 7-10). Malignancy was identified in 45/56 (80.4%, 4 without pathology) biopsy events, including HCC (40/56, 71.4%) and cholangiocarcinoma (CCA) or combined HCC-CCA (5/56, 8.9%). Biopsy quality was highly variable with a median of 40% tumor in each biopsy core (IQR 10-75). Only 43/56 (76.8%) and 23/56 (41.1%) samples met quality thresholds for genomic or metabolomic/proteomic profiling, respectively, requiring expansion of the clinical trial. Overall and major complication rates were 5/60 (8.3%) and 3/60 (5.0%), respectively. Despite uniform biopsy protocol, biopsy quality varied widely with up to 59% of samples to be inadequate for intended purpose. This finding has important consequences for clinical trial design and highlights the need for quality control prior to applications in which the presence of benign cell types may substantially alter findings., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
13. Demographic Trends in Female Interventional Radiology Trainees With the Advent of the Integrated Interventional Radiology Residency.
- Author
-
Parikh RS, Shamimi-Noori S, Reddy S, Gade T, Nadolski GJ, and Hunt SJ
- Subjects
- Demography, Education, Medical, Graduate, Fellowships and Scholarships, Female, Humans, Internship and Residency, Radiology, Interventional education
- Abstract
Objective: Examine changes in gender representation in the interventional radiology (IR) training pool since the advent of the integrated IR residency in 2015 to 2020., Methods: Electronic Residency Application Service and ACGME Data Resource Book records from 2015 to 2020 were reviewed for integrated IR residency and vascular and interventional radiology (VIR) fellowship applicant data and active IR resident and VIR fellow data, respectively. The Society of Interventional Radiology (SIR) 2018 registry data were reviewed for SIR membership data. Two-tailed Fisher's exact tests and χ
2 analyses were used to compare trainees between application cycles., Results: In the 2017 application cycle, 23% (247 of 1,062) of integrated IR residency applicants were female, with similar interest in the 2018, 2019, and 2020 cycles (χ2 [3, n = 2,863] = 5.1, P = .17). In comparison, female VIR fellowship applicants were 12% from 2017 to 2020. Female integrated IR residents represented 13% to 18% of all integrated IR residents in the 2016 to 2020 academic years compared with the period before the integrated IR residency when female IR trainees represented 8% (23 of 275) of all IR trainees in 2015 to 2016 (P = .0002). Although in 2018, the total active SIR female membership was 9% (319 of 3,622), the female resident membership was 17% (131 of 793), and the female medical student membership was 25% (389 of 1,573)., Discussion: With the advent of the integrated IR residency, there is an increasing female constituency, at the medical student, IR applicant, and IR resident levels, with more than a doubling of female IR trainees, portending a continued reduction in the IR gender disparity in the future., (Published by Elsevier Inc.)- Published
- 2021
- Full Text
- View/download PDF
14. Infection Rates Following Hepatic Embolotherapy in Patients with Prior Biliary Interventions: Comparison of Single-Drug Moxifloxacin and Multidrug Antibiotic Prophylaxis.
- Author
-
Parikh RS, Abousoud O, Hunt S, Gade T, Dagli M, Mondschein J, Shamimi-Noori S, Sudheendra D, Stavropoulos SW, Soulen MC, and Nadolski GJ
- Subjects
- Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents adverse effects, Bacterial Infections diagnosis, Bacterial Infections epidemiology, Bacterial Infections microbiology, Carcinoma, Hepatocellular diagnostic imaging, Carcinoma, Hepatocellular mortality, Carcinoma, Hepatocellular pathology, Drug Therapy, Combination, Female, Humans, Incidence, Liver Neoplasms diagnostic imaging, Liver Neoplasms mortality, Liver Neoplasms pathology, Male, Middle Aged, Moxifloxacin adverse effects, Radiopharmaceuticals adverse effects, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Anti-Bacterial Agents administration & dosage, Antibiotic Prophylaxis adverse effects, Bacterial Infections prevention & control, Biliary Tract Surgical Procedures adverse effects, Carcinoma, Hepatocellular therapy, Chemoembolization, Therapeutic adverse effects, Liver Neoplasms therapy, Moxifloxacin administration & dosage, Radiopharmaceuticals administration & dosage
- Abstract
Purpose: To investigate the incidence of infection in patients with prior biliary interventions undergoing hepatic embolotherapy following extended antibiotic prophylaxis using moxifloxacin monotherapy or a multidrug regimen., Material and Methods: Under an Institutional Review Board-approved protocol, retrospective review of a quality assurance database identified all liver-directed therapies (LDTs) at a tertiary care center between 2010 and 2019 with biliary intervention prior to LDT Records were reviewed for infectious complications within 3 months of chemo- or radioembolization. Patients were categorized based on extended antibiotic prophylaxis regimen: oral moxifloxacin monotherapy or multidrug regimen of levofloxacin and metroniodazole plus preprocedural neomycin and erythromycin. Procedures without at least 2 months of clinical follow-up, hepatic ablation, and procedures without extended antibiotic prophylaxis were excluded Regression analysis was used to analyze multivariate data to detect a difference in infection rate., Results: Twenty-four chemoembolization and 58 radioembolization procedures were performed on 55 patients with prior biliary interventions. Forty-four used monotherapy and 38 used multidrug regimen. The incidence of infection was 16.7% (4/24) after chemoembolization and 13.8% (8/58) after radioembolization The incidence of infection in patients did not differ between antibiotic prophylaxis regimens (18.2% [8/44] with moxifloxacin monotherapy and 10.5% [4/38] multidrug regimen, P = .3) or between types of biliary interventions (24.1% [7/29] with bilioenteric anastomosis and 23.8% [5/21] biliary stenting, P = .3)., Conclusions: The types of extended antibiotic prophylaxis (moxifloxacin monotherapy vs multitherapy), prior biliary intervention, and embolotherapy were not found to be associated with differences in the incidence of infectious complications in this population., (Copyright © 2021 SIR. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
15. US-triggered Microbubble Destruction for Augmenting Hepatocellular Carcinoma Response to Transarterial Radioembolization: A Randomized Pilot Clinical Trial.
- Author
-
Eisenbrey JR, Forsberg F, Wessner CE, Delaney LJ, Bradigan K, Gummadi S, Tantawi M, Lyshchik A, O'Kane P, Liu JB, Intenzo C, Civan J, Maley W, Keith SW, Anton K, Tan A, Smolock A, Shamimi-Noori S, and Shaw CM
- Subjects
- Aged, Carcinoma, Hepatocellular diagnostic imaging, Female, Humans, Image Enhancement methods, Liver Neoplasms diagnostic imaging, Male, Pilot Projects, Reproducibility of Results, Treatment Outcome, Brachytherapy methods, Carcinoma, Hepatocellular radiotherapy, Contrast Media, Liver Neoplasms radiotherapy, Microbubbles, Ultrasonography methods
- Abstract
Background US contrast agents are gas-filled microbubbles (MBs) that can be locally destroyed by using external US. Among other bioeffects, US-triggered MB destruction, also known as UTMD, has been shown to sensitize solid tumors to radiation in preclinical models through localized insult to the vascular endothelial cells. Purpose To evaluate the safety and preliminary efficacy of combining US-triggered MB destruction and transarterial radioembolization (TARE) in participants with hepatocellular carcinoma (HCC). Materials and Methods In this pilot clinical trial, participants with HCC scheduled for sublobar TARE were randomized to undergo either TARE or TARE with US-triggered MB destruction 1-4 hours and approximately 1 and 2 weeks after TARE. Enrollment took place between July 2017 and February 2020. Safety of US-triggered MB destruction was evaluated by physiologic monitoring, changes in liver function tests, adverse events, and radiopharmaceutical distribution. Treatment efficacy was evaluated by using modified Response Evaluation Criteria in Solid Tumors (mRECIST) on cross-sectional images, time to required next treatment, transplant rates, and overall survival. Differences across mRECIST reads were compared by using a Mann-Whitney U test, and the difference in prevalence of tumor response was evaluated by Fisher exact test, whereas differences in time to required next treatment and overall survival curves were compared by using a log-rank (Mantel-Cox) test. Results Safety results from 28 participants (mean age, 70 years ± 10 [standard deviation]; 17 men) demonstrated no significant changes in temperature ( P = .31), heart rate ( P = .92), diastolic pressure ( P = .31), or systolic pressure ( P = .06) before and after US-triggered MB destruction. No changes in liver function tests between treatment arms were observed 1 month after TARE ( P > .15). Preliminary efficacy results showed a greater prevalence of tumor response (14 of 15 [93%; 95% CI: 68, 100] vs five of 10 [50%; 95% CI: 19, 81]; P = .02) in participants who underwent both US-triggered MB destruction and TARE ( P = .02). Conclusion The combination of US-triggered microbubble destruction and transarterial radioembolization is feasible with an excellent safety profile in this patient population and appears to result in improved hepatocellular carcinoma treatment response. © RSNA, 2020.
- Published
- 2021
- Full Text
- View/download PDF
16. Medical Student Education During the COVID-19 Pandemic: Initial Experiences Implementing a Virtual Interventional Radiology Elective Course.
- Author
-
DePietro DM, Santucci SE, Harrison NE, Kiefer RM, Trerotola SO, Sudheendra D, and Shamimi-Noori S
- Subjects
- Curriculum, Humans, Pandemics, Radiology, Interventional education, SARS-CoV-2, COVID-19, Students, Medical
- Abstract
Rationale and Objectives: In response to the COVID-19 pandemic reducing medical student presence on clinical services and in classrooms, academic institutions are utilizing a virtual format to continue medical student education. We describe a successful initial experience implementing a virtual elective in interventional radiology (IR) and provide the course framework, student feedback, and potential improvements., Materials and Methods: A 2-week virtual IR elective curriculum was created utilizing a combination of synchronous and asynchronous learning and the "flipped" classroom educational model. Students virtually participated in daily IR resident education conferences, resident-led case review sessions, and dedicated lectures. Asynchronous prelearning material consisted of text and video correlating to lecture topics. Anonymous precourse and postcourse surveys were sent to all participating students (n = 10)., Results: Ten students (100%) completed precourse and seven (70%) completed postcourse surveys. Enrolled students were considering residencies in surgery (50%), internal medicine (40%), interventional radiology (30%), and/or diagnostic radiology (30%). Students' understanding of what IRs do and the procedures they perform (p < 0.001), when to consult IR for assistance in patient management (p = 0.005), and the number of IR procedures students could recall (p = 0.015) improved after the course. Case-review sessions and virtual lectures ranked as having the highest education value. Students recommended additional small-group case workshops., Conclusion: This successful virtual IR elective provides a framework for others to continue IR medical student education during the pandemic and grow the specialty's presence within an increasingly virtual medical school curriculum. The described model may be modified to improve IR education beyond the COVID-19 era., (Copyright © 2020 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
17. Interventional Oncology Approach to Hepatic Metastases.
- Author
-
O'Leary C, Soulen MC, and Shamimi-Noori S
- Abstract
Metastatic liver disease is one of the major causes of cancer-related morbidity and mortality. Locoregional therapies offered by interventional oncologists alleviate cancer-related morbidity and in some cases improve survival. Locoregional therapies are often palliative in nature but occasionally can be used with curative intent. This review will discuss important factors to consider prior to palliative and curative intent treatment of metastatic liver disease with locoregional therapy. These factors include those specific to the tumor, liver function, liver reserve, differences between treatment modalities, and patient-specific considerations., Competing Interests: Conflict of Interest Michael Soulen: Research Grants: Guerbet, Boston Scientific, Sirtex, Consultant: Guerbet, Genentech, Instylla. Susan Shamimi-Noori: Consultant: Boston Scientific, Sirtex., (Thieme. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
18. Response to Letter to the Editor.
- Author
-
Shamimi-Noori S, Mantell MP, Vance AZ, Trerotola SO, and Clark TWI
- Subjects
- Case-Control Studies, Renal Dialysis
- Published
- 2020
- Full Text
- View/download PDF
19. Comparison of Clinical Performance of VectorFlow and Palindrome Symmetric-Tip Dialysis Catheters: A Multicenter, Randomized Trial.
- Author
-
Nadolski GJ, Redmond J, Shin B, Shamimi-Noori S, Vance A, Hammelman B, Clark TWI, Cohen R, and Rudnick M
- Subjects
- Aged, Biomarkers blood, Catheter Obstruction etiology, Catheterization, Central Venous adverse effects, Device Removal, Equipment Design, Female, Humans, Kidney Failure, Chronic diagnosis, Kidney Failure, Chronic physiopathology, Male, Middle Aged, Philadelphia, Prospective Studies, Renal Dialysis adverse effects, Risk Factors, Time Factors, Treatment Outcome, Urea blood, Catheterization, Central Venous instrumentation, Catheters, Indwelling, Central Venous Catheters, Hemodynamics, Kidney Failure, Chronic therapy, Renal Dialysis instrumentation
- Abstract
Purpose: To compare clinical performance of 2 widely used symmetric-tip hemodialysis catheters., Materials and Methods: Patients with end-stage renal disease initiating or resuming hemodialysis were randomized to receive an Arrow-Clark VectorFlow (n = 50) or Palindrome catheter (n = 50). Primary outcome was 90-d primary unassisted catheter patency. Secondary outcomes were Kt/V ([dialyzer urea clearance × total treatment time]/total volume of urea distribution), urea reduction ratio (URR), and effective blood flow (Q
B )., Results: Primary unassisted patency rates with the VectorFlow catheter at 30, 60, and 90 d were 95.5% ± 3.3, 87.2% ± 7.3, and 80.6% ± 9.8, respectively, compared with 89.1% ± 6.2, 79.4% ± 10.0, and 71.5% ± 12.6 with the Palindrome catheter (P = .20). Patients with VectorFlow catheters had a mean Kt/V of 1.5 at 30-, 60-, and 90-day time points, significantly higher than the mean Kt/V of 1.3 among those with Palindrome catheters (P = .0003). URRs were not significantly different between catheters. Catheter QB rates exceeded National Kidney Foundation-recommended thresholds of 300 mL/min at all time points for both catheters and were similar for both catheters (median, 373 mL/min). Catheter failure, ie, poor flow rate requiring guide-wire exchange or removal, within the 90-day primary outcome occurred in 3 VectorFlow subjects and 5 Palindrome subjects (P = .72). Infection rates were similar, with 0.98 infections per 1,000 catheter days for VectorFlow catheters compared with 2.62 per 1,000 catheter days for Palindrome catheters (P = .44)., Conclusions: The 90-day primary patency rates of Palindrome and VectorFlow catheters were not significantly different, and both achieved sustained high QB through 90 day follow-up. However, dialysis adequacy based on Kt/V was consistently better with the VectorFlow catheter versus the Palindrome., (Copyright © 2020 SIR. Published by Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
20. Diagnosis and Treatment of Nonmaturing Fistulae for Hemodialysis Access via Transradial Approach: A Case-Control Study.
- Author
-
Shamimi-Noori S, Sheng M, Mantell MP, Vance AZ, Cohen R, Trerotola SO, Reddy SN, Nadolski GJ, Stavropoulos SW, and Clark TWI
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Graft Occlusion, Vascular diagnostic imaging, Graft Occlusion, Vascular etiology, Graft Occlusion, Vascular physiopathology, Humans, Male, Middle Aged, Punctures, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Vascular Patency, Arteriovenous Shunt, Surgical adverse effects, Brachial Artery diagnostic imaging, Brachial Artery physiopathology, Catheterization, Peripheral adverse effects, Endovascular Procedures adverse effects, Graft Occlusion, Vascular therapy, Radial Artery diagnostic imaging, Radial Artery physiopathology, Renal Dialysis
- Abstract
Purpose: To compare outcomes of transradial access for endovascular treatment of nonmaturing hemodialysis fistulae compared to brachial arteriography followed by unidirectional or bidirectional fistula access for intervention., Materials and Methods: In this institutional review board-approved, retrospective, case-control study, 56 consecutive patients with nonmaturing arteriovenous fistulae underwent percutaneous intervention between 2015 and 2018. The transradial group (n = 28) underwent radial artery access for diagnostic fistulography and intervention. The control group (n = 28) underwent retrograde brachial artery access for fistulography followed by unidirectional/bidirectional fistula access for intervention. Both groups had similar demographics, fistula characteristics, and stenosis locations., Results: Fewer punctures were required in the transradial group compared to controls (1.2 vs 2.4, P < .0001), and procedure time was shorter (64.9 vs 91.3 minutes, P = .0016). Anatomic, technical, and clinical success rates trended higher in the transradial group compared to controls (93% vs 86%, 96% vs 89%, and 82% vs 64%, respectively). Nonmaturation resulting in fistula abandonment was lower in the transradial group (3.7% vs 25%, P = .025). Primary unassisted patency at 3, 6, and 12 months was 77.1% ± 8.2%, 73.1% ± 8.7%, and 53.3% ± 10.6% in the transradial group, respectively, and 63.0% ± 9.3%, 55.6% ± 9.6%, and 48.1% ± 9.6% in the control group, respectively (P = .76). Primary assisted patency at 12 months was 92.3% ± 5.3% in the transradial group compared to 61.8% ± 9.6% at 12 months in the control group (P = .021). No major complications occurred. Minor complications were lower in the transradial group than in the control group (14% vs 39%, P = .068)., Conclusions: Treatment of nonmaturing fistulae via a transradial approach was safe, improved midterm patency, and was associated with lower rates of fistula abandonment., (Copyright © 2020 SIR. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
21. Nonfemoral Arterial Hemostasis Following Percutaneous Intervention Using a Focused Compression Device.
- Author
-
Barrette LX, Vance AZ, Shamimi-Noori S, Nadolski GP, Reddy S, Kratz KM, Redmond JW, and Clark TWI
- Subjects
- Female, Humans, Lower Extremity blood supply, Lower Extremity surgery, Male, Middle Aged, Time Factors, Treatment Outcome, Upper Extremity blood supply, Upper Extremity surgery, Hemostasis physiology, Hemostatic Techniques instrumentation, Intermittent Pneumatic Compression Devices, Vascular Surgical Procedures methods
- Abstract
Purpose: Upper extremity and tibiopedal arterial access are increasingly used during endovascular therapies. Balloon compression hemostasis devices in these anatomic locations have been described, but most utilize a compression surface extending well beyond the puncture site. We report single-center experience with an arterial puncture-focused compression device following upper extremity and tibiopedal access., Patients and Methods: A series of 249 focused compression hemostasis devices (VasoStat, Forge Medical, Bethlehem, Pennsylvania, USA) were used in 209 patients following lower extremity (n = 63) and upper extremity (n = 186; radial: 90%) arterial access procedures using 4-7 French sheaths. Demographic, operative, and follow-up data were collected. Logistic regression was used to evaluate potential association between patient/operative variables and time to hemostasis., Results: Primary hemostasis was achieved in 97.2% (242/249) following sheath removal; in 7 cases (2.8%) puncture site oozing occurred after initial device removal and required reapplication. Secondary hemostasis was 100% (249/249). Seven complications (2.8%) were recorded: 5 minor hematomas (2%) and 2 transient access artery occlusions (0.8%). Mean time to hemostasis enabling device removal was 55 ± 28 min. Elevated body mass index (BMI) was not associated with increased time to hemostasis (p = 0.31). Accessed artery, sheath size, and heparin dose were also not associated with time to hemostasis (p = 0.64; p = 0.74; p = 0.75, respectively)., Conclusions: The focused compression hemostasis device enabled rapid hemostasis with a low complication rate. Time to hemostasis was independent of BMI, access site, sheath size, or heparin dose.
- Published
- 2020
- Full Text
- View/download PDF
22. Iatrogenic celiac and hepatic artery dissections during intra-arterial regional tumor therapies: a 16-year retrospective review.
- Author
-
Alexander ES, Nadolski GJ, Soulen MC, Stavropoulos SW, Hunt SJ, Gade TP, Itkin M, and Shamimi-Noori S
- Subjects
- Aged, Angiography, Chemoembolization, Therapeutic adverse effects, Female, Humans, Iatrogenic Disease, Male, Middle Aged, Retrospective Studies, Tomography, X-Ray Computed, Vascular Patency, Brachytherapy adverse effects, Celiac Artery diagnostic imaging, Celiac Artery injuries, Embolization, Therapeutic adverse effects, Hepatic Artery diagnostic imaging, Hepatic Artery injuries, Liver Neoplasms therapy
- Abstract
Purpose: To identify the incidence and outcomes of iatrogenic celiac and hepatic artery dissections during transarterial therapies, including bland embolization, chemoembolization, radioembolization (TARE), and pre-TARE scintigraphic mapping., Methods: The institution's quality assessment database, electronic medical record, and picture archiving and communication system were reviewed to identify all patients who underwent transarterial locoregional therapy from 1/2001 to 7/2017 and to determine the incidence of iatrogenic dissection, to assess patency of the arteries after dissection, and to assess the ability to complete therapy., Results: 2253 patients underwent 3776 transarterial hepatic oncology procedures. Among 3776 procedures, 40 (1.1%) were associated with dissection of the visceral vasculature, affecting 39 patients (1.7%). The incidence of flow-limiting dissections was 0.3% (13/3776) and non-flow-limiting dissections was 0.7% (27/3776). After dissection, 68% (27/40) of treatments were completed the same day. Among the 13 aborted treatments, 8 (62%) were completed on a subsequent encounter. Follow-up imaging was obtained in 26 of 40 cases at median time of 63 days. Complete resolution of the dissection was seen in 15/26 cases (58%), near complete resolution (< 30% luminal narrowing) in 3/26 (12%), unchanged appearance of a non-flow-limiting dissection in 4/26 (15%), progressive luminal narrowing in 3/26 (12%), and complete occlusion in 1/26 (4%)., Conclusion: Iatrogenic dissections of visceral arteries rarely occur during tumor embolization procedures. 35/39 (90%) of patients underwent successful treatment despite the dissection.
- Published
- 2019
- Full Text
- View/download PDF
23. Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data.
- Author
-
Shamimi-Noori S, Gonsalves CF, and Shaw CM
- Abstract
Metastatic liver disease is a major cause of cancer-related morbidity and mortality. Surgical resection is considered the only curative treatment, yet only a minority is eligible. Patients who present with unresectable disease are treated with systemic agents and/or locoregional therapies. The latter include thermal ablation and catheter-based transarterial interventions. Thermal ablation is reserved for those with limited tumor burden. It is used to downstage the disease to enable curative surgical resection, as an adjunct to surgery, or in select patients it is potentially curative. Transarterial therapies are indicated in those with more diffuse disease. The goals of care are to palliate symptoms and prolong survival. The indications and supporting data for thermal ablation and transarterial interventions are reviewed, technical and tumor factors that need to be considered prior to intervention are outlined, and finally several cases are presented.
- Published
- 2017
- Full Text
- View/download PDF
24. Ultrasound and CT-directed liver biopsy.
- Author
-
Shaw C and Shamimi-Noori S
- Published
- 2014
- Full Text
- View/download PDF
25. Age- and limb-related differences in the vasoconstrictor response to limb dependency are not mediated by a sympathetic mechanism in humans.
- Author
-
Snyder KA, Shamimi-Noori S, Wilson TE, and Monahan KD
- Subjects
- Adrenergic Antagonists pharmacology, Adult, Aged, Blood Pressure physiology, Brachial Artery physiology, Female, Heart Rate physiology, Humans, Male, Middle Aged, Phentolamine pharmacology, Popliteal Artery physiology, Propranolol pharmacology, Regional Blood Flow physiology, Sympathetic Nervous System drug effects, Vascular Resistance physiology, Aging physiology, Arm blood supply, Arm innervation, Leg blood supply, Leg innervation, Sympathetic Nervous System physiology, Vasoconstriction physiology
- Abstract
Aims: We tested the hypotheses that vasoconstrictor responses to limb dependency are: (i) greater in the leg than the arm, (ii) impaired with age and (iii) not sympathetically mediated., Methods: Vascular responses to limb dependency (i.e. lowering the limb from heart level to 30 cm below heart level) were determined in 17 young and 17 older adults. Indices of blood flow were obtained in the brachial and popliteal arteries (Doppler ultrasound) as well as in the cutaneous circulation (forearm and calf using laser-Doppler flowmetry). Vasoconstriction was quantified by calculating the indices of vascular resistance as height corrected mean arterial pressure/limb blood velocity or skin flux. A second group of subjects repeated the limb dependency trials after acute systemic sympathetic blockade., Results: Limb dependency increased vascular resistance index in the brachial artery (∆59 ± 8%; P<0.05) and popliteal artery (∆99 ± 10%; P<0.05 for change in heart level and brachial vs. popliteal) of young and older adults (∆60 + 9% brachial and ∆61 ± 7% popliteal arteries; P<0.05 for change in heart level and response in popliteal young vs. older adults). In contrast, cutaneous vasoconstrictor responses to limb dependency were similar in the forearm (∆218 ± 29% and ∆200 ± 29% for young and older adults, respectively) and calf (∆257 ± 32% and ∆236 ± 29%; all P<0.05 from heart level) of young and older adults. Vasoconstrictor responses to limb dependency were not affected by sympathetic blockade in young or older adults., Conclusion: These findings indicate that age-, limb-, and tissue-related differences may exist in the vasoconstrictor response to limb dependency in healthy humans, which are not sympathetically mediated., (© 2012 The Authors Acta Physiologica © 2012 Scandinavian Physiological Society.)
- Published
- 2012
- Full Text
- View/download PDF
26. Adrenergic mechanisms do not contribute to age-related decreases in calf venous compliance.
- Author
-
Sielatycki JA, Shamimi-Noori S, Pfeiffer MP, and Monahan KD
- Subjects
- Adult, Aged, Elasticity physiology, Humans, Leg blood supply, Male, Middle Aged, Vascular Resistance physiology, Aging physiology, Receptors, Adrenergic metabolism, Veins physiology
- Abstract
Limb venous compliance decreases with advancing age, even in healthy humans. To test the hypothesis that adrenergic mechanisms contribute to age-associated reductions in limb venous compliance, we measured calf venous compliance before and during acute systemic α- and β-adrenergic blockade in eight young (27 ± 1 yr old, mean ± SE) and eight older healthy men (67 ± 2 yr old). Calf venous compliance was determined in supine subjects by inflating a thigh-collecting cuff to 60 mmHg for 8 min and then decreasing it (1 mmHg/s) to 0 mmHg while calf volume was indexed with a strain gauge. The slope (·10⁻³) of the pressure-compliance relation (compliance= β₁ + 2·β₂·cuff pressure), which is the first derivative of the quadratic pressure-volume relation [(Δlimb volume) = β₀+ β₁·(cuff pressure) + β₂·(cuff pressure)²] during reductions in cuff pressure, was used to quantify calf venous compliance. Calf venous compliance was ∼30% lower (P < 0.01) in older compared with young men before adrenergic blockade. In response to adrenergic blockade calf venous compliance did not increase in young (-2.62 ± 0.14 and -2.29 ± 0.18 ml·dl⁻¹·mmHg⁻¹, before and during blockade, respectively) or older men (-1.78 ± 0.27 and -1.68 ± 0.21 ml·dl⁻¹ ·mmHg⁻¹). Moreover, during adrenergic blockade differences in calf venous compliance between young and older men observed before adrenergic blockade persisted. Collectively, these data strongly suggest that adrenergic mechanisms neither directly restrain calf venous compliance in young or older men nor do they contribute to age-associated reductions in calf venous compliance in healthy men.
- Published
- 2011
- Full Text
- View/download PDF
27. Relationship of inferior vena cava filter usage in post-surgical patients by various surgical and medical subspecialists.
- Author
-
Marmor DB, Merli GJ, Whellan DJ, Andrel J, Fisicaro T, Shamimi-Noori S, Adams S, Rubin A, and Feldman AM
- Subjects
- Female, Humans, Male, Postoperative Period, Retrospective Studies, Time Factors, Treatment Outcome, Medicine statistics & numerical data, Postoperative Complications prevention & control, Pulmonary Embolism prevention & control, Specialization, Specialties, Surgical statistics & numerical data, Vena Cava Filters statistics & numerical data, Vena Cava, Inferior, Venous Thrombosis prevention & control
- Abstract
Venous thromboembolism is a common and often fatal problem in postsurgical patients. These patients are usually treated with either therapeutic anticoagulation or the placement of inferior vena cava (IVC) filters. Controversy surrounds the use of IVC filters, because no data exist proving survival benefit. In this study, 264 inpatient medical records of patients who underwent major surgical procedures and had the diagnosis of deep venous thrombosis or pulmonary embolism were examined. Among these patients, those who received IVC filters were identified, and the documented indications for filter placement were reviewed. Rates of IVC filter placement per venous thromboembolism event and specific indications were examined across surgical subspecialties and by type of medical consultant. Sixty percent of patients received IVC filters. IVC filter placement rates varied significantly across surgical subspecialties (p <0.0001), with the highest rate in the orthopedic surgery subgroup (80%). Rates of IVC filter use also differed significantly (p <0.0007) between medical consultants who specialized in antithrombotic medicine (46.8%) and those who did not (68.3%). Significant differences also existed in specific indications for filter placement between medical and surgical subspecialties. In conclusion, most of this study's population received IVC filters. Rates of IVC filter placement varied by the specialties of surgeons and medical consultants. The heterogeneity of treatment strategies coupled with the lack of data for this patient population highlights the need for future prospective studies to guide evidence-based treatment.
- Published
- 2008
- Full Text
- View/download PDF
28. Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway.
- Author
-
Shamimi-Noori S, Yeow WS, Ziauddin MF, Xin H, Tran TL, Xie J, Loehfelm A, Patel P, Yang J, Schrump DS, Fang BL, and Nguyen DM
- Subjects
- Adenoviridae genetics, Animals, Antineoplastic Agents pharmacology, Caspase 9 genetics, Cell Line, Tumor, Cell Survival drug effects, Esophageal Neoplasms genetics, Esophageal Neoplasms pathology, Esophageal Neoplasms therapy, Female, Humans, Lung Neoplasms genetics, Lung Neoplasms pathology, Lung Neoplasms therapy, Mice, Mice, Nude, Mitochondria metabolism, Neoplasms genetics, Neoplasms pathology, RNA, Small Interfering genetics, Signal Transduction drug effects, TNF-Related Apoptosis-Inducing Ligand genetics, Xenograft Model Antitumor Assays, Cisplatin pharmacology, Genetic Therapy methods, Neoplasms therapy, TNF-Related Apoptosis-Inducing Ligand physiology
- Abstract
Despite adequately expressing tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors DR4/DR5, malignant cells are frequently refractory to the cytotoxic effect of this apoptosis-inducing ligand. The susceptibility of cancer cells to TRAIL can be potentiated by cisplatin (CDDP). This study was designed to evaluate the ability of cisplatin to enhance the cytotoxic effect of TRAIL gene therapy using the recombinant adenovirus-mediated tumor-selective expression of membrane-bound green fluorescence protein (GFP)-TRAIL fusion protein (AdVgTRAIL) on thoracic cancer cells and to elucidate the putative mechanisms responsible for this synergistic combination effect. While causing little death of cultured thoracic cancer cells by itself, AdVgTRAIL in combination with CDDP, on the other hand, mediated profound supra-additive cytotoxicity and apoptosis via a strong bystander effect. CDDP/AdVgTRAIL-induced cytotoxicity was completely abrogated either by the pancaspase inhibitor zVAD-fmk or by the selective caspase 9 inhibitor or by transient knockdown of caspase 9 by siRNA, indicating that this process was caspase-mediated and mitochondria-dependent. This was confirmed by the observation that Bcl2 overexpression protected the cells from combination-induced cytotoxicity. Robust activation of caspase 8 activity in combination-treated cells was blocked by overexpression of Bcl2, indicating that caspase 8 activation was secondary to the mitochondria-mediated amplification feedback loop. Combining CDDP with AdVgTRAIL greatly enhances its tumoricidal efficacy in cultured thoracic cancer cells in vitro. The two agents interact to mediate profound activation of caspase cascade via recruitment of the mitochondria and positive feedback loop. The CDDP/AdVgTRAIL combination also exhibits a strong antitumor effect in in vivo animal model of human cancer xenografts.
- Published
- 2008
- Full Text
- View/download PDF
29. Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01.
- Author
-
Yeow WS, Ziauddin MF, Maxhimer JB, Shamimi-Noori S, Baras A, Chua A, Schrump DS, and Nguyen DM
- Subjects
- Apoptosis drug effects, Dose-Response Relationship, Drug, Drug Synergism, Humans, NF-kappa B genetics, NF-kappa B metabolism, Neoplasms pathology, Tumor Cells, Cultured, Anticonvulsants pharmacology, Antineoplastic Agents pharmacology, Enzyme Inhibitors pharmacology, Histone Deacetylase Inhibitors, Neoplasms drug therapy, Staurosporine analogs & derivatives, Staurosporine pharmacology, Valproic Acid pharmacology
- Abstract
Histone deacetylase inhibitors (HDACIs) are novel anticancer agents with potent cytotoxicity against a wide range of malignancies. We have previously demonstrated that either Calphostin C (CC) (a protein kinase C (PKC) inhibitor) or Parthenolide (an NF-kappaB inhibitor) abrogates HDACI-induced transcriptional activation of NF-kappaB and p21, which is associated with profound potentiation of HDACI-mediated induction of apoptosis. Valproic acid (VA), a commonly used antiepileptic agent, has recently been shown to be an HDACI. This study was aimed to evaluate the anticancer property of VA in thoracic cancer cells and the development of clinically relevant strategies to enhance VA-mediated induction of apoptosis using kinase inhibitors Staurosporine (STP) or its analogue UCN-01. Treating cultured thoracic cancer cells with VA (0.62-10.0 mM) resulted in significant cell line- and dose-dependent growth inhibition (IC(50) values: 4.1-6.0 mM) and cell cycle arrest at G1/S checkpoint with profound accumulation of cells at G0/G1 phase but little induction of apoptosis. Valproic acid, being an HDACI, caused significant dose-dependent accumulation of hyperacetylated histones, following 24 h of treatment. Valproic acid-mediated 5-20-fold upregulation of transcriptional activity of NF-kappaB was substantially (50-90%) suppressed by cotreatment with CC, STP or UCN-01. Whereas minimal death (<20%) was observed in cells treated with either VA (1.0 or 5.0 mM) alone or kinase inhibitors alone, 60-90% of cells underwent apoptosis following exposure to combinations of VA+kinase inhibitors. Kinase inhibitor-mediated suppression of NF-kappaB transcriptional activity played an important role in sensitising cancer cells to VA as direct inhibition of NF-kappaB by Parthenolide drastically synergised with VA to induce apoptosis (VA+Parthenolide: 60-90% compared to <20% following single-drug treatments). In conclusion, VA, a well-known antiepileptic drug, has mild growth-inhibitory activity on cultured cancer cells. The weak VA-mediated induction of apoptosis of thoracic cancer cells can be profoundly enhanced either by Parthenolide, a pharmacologic inhibitor of NF-kappaB, or by UCN-01 a kinase inhibitor that has already undergone phase I clinical development. Combinations of VA with either a PKC inhibitor or an NF-kappaB inhibitor are promising novel molecularly targeted therapeutics for thoracic cancers.
- Published
- 2006
- Full Text
- View/download PDF
30. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR.
- Author
-
Olszewski RT, Bukhari N, Zhou J, Kozikowski AP, Wroblewski JT, Shamimi-Noori S, Wroblewska B, Bzdega T, Vicini S, Barton FB, and Neale JH
- Subjects
- Animals, Behavior, Animal drug effects, Cells, Cultured, Disease Models, Animal, Enzyme Inhibitors chemical synthesis, Enzyme Inhibitors pharmacology, Male, Phencyclidine, Rats, Rats, Sprague-Dawley, Schizophrenia chemically induced, Urea analogs & derivatives, Urea chemical synthesis, Urea pharmacology, Glutamate Carboxypeptidase II antagonists & inhibitors, Motor Activity drug effects, Receptors, Metabotropic Glutamate metabolism, Schizophrenia drug therapy, Stereotyped Behavior drug effects
- Abstract
Phencyclidine (PCP) administration elicits positive and negative symptoms that resemble those of schizophrenia and is widely accepted as a model for the study of this human disorder. Group II metabotropic glutamate receptor (mGluR) agonists have been reported to reduce the behavioral and neurochemical effects of PCP. The peptide neurotransmitter, N-acetylaspartylglutamate (NAAG), is a selective group II agonist. We synthesized and characterized a urea-based NAAG analogue, ZJ43. This novel compound is a potent inhibitor of enzymes, glutamate carboxypeptidase II (K(i) = 0.8 nM) and III (K(i) = 23 nM) that deactivate NAAG following synaptic release. ZJ43 (100 microM) does not directly interact with NMDA receptors or metabotropic glutamate receptors. Administration of ZJ43 significantly reduced PCP-induced motor activation, falling while walking, stereotypic circling behavior, and head movements. To test the hypothesis that this effect of ZJ43 was mediated by increasing the activation of mGluR3 via increased levels of extracellular NAAG, the group II mGluR selective antagonist LY341495 was co-administered with ZJ43 prior to PCP treatment. This antagonist completely reversed the effects of ZJ43. Additionally, LY341495 alone increased PCP-induced motor activity and head movements suggesting that normal levels of NAAG act to moderate the effect of PCP on motor activation via a group II mGluR. These data support the view that NAAG peptidase inhibitors may represent a new therapeutic approach to some of the components of schizophrenia that are modeled by PCP.
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.